Alejandro Dorenbaum - Dec 10, 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role: Chief Medical Officer
Signature: /s/ Vineet R. Jindal, Attorney-in-Fact
Stock symbol: RPHM
Transactions as of: Dec 10, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/14/2021, 03:30 PM
Next filing: Dec 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPHM	Common Stock	Award	$0	+30K	+134.24%	$0.00	52.3K	Dec 10, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPHM	Stock option (right to buy)	Award	$0	+100K		$0.00	100K	Dec 10, 2021	Common Stock	100K	$6.69	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit award.
F2	The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Persons's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.